DiaMedica Therapeutics (DMAC) Financials

$6.47

$0.00 (0.00%)

As on 11-Sep-2026 16:00EDT

Market cap

$364 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

9.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-29.06	-22.08	-18.73	-11.51	-12.25
Cash Flow from Investing Activities	--	-2.19	8.56	-18.30	11.54	-20.54
Cash from Financing Activities	--	43.88	11.99	36.84	-0.01	30.09
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.73	-0.70	-0.57	-0.51	-0.52	-0.71
Cash EPS ($)	--	-0.70	-0.57	-0.51	-0.52	-0.71
Adjusted Book Value ($)	--	1.19	0.95	1.35	1.20	2.31
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.62	-0.52	-0.49	-0.44	-0.64
Free Cash Flow per Share ($)	--	-0.62	-0.52	-0.49	-0.44	-0.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-67.28	-52.84	-46.28	-35.81	-38.72
ROE (%)	-79.49	-67.68	-53.27	-46.77	-36.06	-38.81
ROA (%)	-86.12	-60.84	-48.64	-43.77	-34.21	-36.91
EBIT Margin (%)	133,972.64	--	--	--	--	--
Net Margin (%)	134,079.79	--	--	--	--	--
Cash Profit Margin (%)	2.58	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-100.20	--	--	--	--	--
EBIT Growth (%)	-26.93	-34.10	-26.25	-41.69	-0.62	-6.81
Net Profit Growth (%)	-26.91	-34.05	-26.12	-41.72	-0.62	-10.58
EPS Growth (%)	-6.40	-0.22	-0.12	0.01	0.28	0.03
Book Value Growth (%)	12.47	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-11.41	-9.51	-5.56	-3.06	-5.22
Price / Book Value	9.06	6.66	5.71	2.11	1.31	1.61
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.96	-9.61	-7.74	-2.86	-0.64	-1.92
Close Price ($)	7.04	7.96	5.43	2.84	1.58	3.73
High Price ($)	10.42	10.42	6.41	4.75	3.94	10.88
Low Price ($)	3.48	3.19	2.14	1.27	1.12	3.00
Market Cap ($ Cr)	364.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.01	0.01	0.01	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	6.72	11.81	8.28	19.27	15.61	29.82
Quick Ratio	6.72	--	--	--	--	29.74
Interest Coverage	--	--	--	--	-38.66	-165.41

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	-28.57	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	1,650.93	935.95
Payable days	--	--	8,737.90	10,105.25	9,080.12	12,235.88
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.